Sanofi India Declares ₹75 Interim Dividend; TDS Guidelines Issued

Sanofi India Limited announced the declaration of an interim dividend of ₹75 per equity share for the financial year 2026. The dividend will be paid to shareholders whose names appear on the company's register of members and as beneficial owners by the close of business hours on November 5, 2026, which has been set as the record date.

The company has issued detailed communication to its shareholders regarding the applicability of Tax Deduction at Source (TDS) on this interim dividend, in accordance with the Income Tax Act, 2025. Shareholders are required to update crucial details such as residential status, PAN, category, email address, and residential address with the company's Registrar and Share Transfer Agent (RTA) or their Depository Participant on or before the record date of November 5, 2026. Specific procedures and documentation requirements for both resident and non-resident shareholders are outlined to ensure appropriate tax deduction.

For resident individual shareholders, no TDS will be deducted if the aggregate dividend amount does not exceed ₹10,000. If the PAN is valid, TDS will be deducted at 10%, unless Form 121 is provided and eligibility conditions are met, in which case no TDS will be deducted. If the PAN is unavailable or invalid, TDS will be deducted at 20% or the prescribed TDS rate, whichever is higher. Non-resident shareholders will generally be subject to a 20% TDS, plus applicable surcharge and cess, though they may opt for beneficial Double Taxation Avoidance Treaty (DTAA) rates by providing specific documentation. The company emphasized that scanned copies of all required documents must be submitted through the provided portal by November 5, 2026, 5:00 p.m. IST.